Synonyms: MK-0787 | MK0787 | Primaxin® (imipenem + cilastatin) | Recarbrio® (imipenem + cilastatin + relebactam).
imipenem is an approved drug (FDA (1985), UK (1988))
Compound class:
Synthetic organic
Comment: Imipenem is a broad-spectrum, semi-synthetic, intravenous β-lactam carbapenem derived from thienamycin.
|
|
No information available. |
Summary of Clinical Use ![]() |
Imipenem was first approved by the FDA in November 1985 as a component of fixed-dose combination product Primaxin (imipenem + cilastatin). It is also available in a triple combination with cilastatin and relebactam (Recarbrio). |